|
000
| 01524nam 2200277za 4500 |
|---|
| 001 | 9.822393 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107143654 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 160810s2016||||onc|||||o f00| 0 eng d |
|---|
| 020 | |a978-0-660-06022-4 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aMR4-53/2016E-PDF |
|---|
| 245 | 00|aHuman germline gene editing |h[electronic resource] : |bpoints to consider from a Canadian perspective. |
|---|
| 260 | |aOttawa : |bCanadian Institutes of Health Research, |c2016. |
|---|
| 300 | |a7 p. |
|---|
| 500 | |aIssued also in French under title: Édition génique de la lignée germinale humaine : points à prendre en considération dans le contexte canadien. |
|---|
| 500 | |a"December 2016." |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 520 | |a"This document outlines Points to Consider about human germline gene editing and the applications of gene editing technologies in human embryos in the Canadian context. Gene editing in human germline cells is prohibited under the Assisted Human Reproduction Act. These Points to Consider are designed to inform future discussions in this area for research, teaching, and outreach"--Executive Summary. |
|---|
| 692 | 07|2gccst|aGenetically modified organisms |
|---|
| 692 | 07|2gccst|aStem cells |
|---|
| 710 | 2 |aCanadian Institutes of Health Research. |
|---|
| 775 | 08|tÉdition génique de la lignée germinale humaine |w(CaOODSP)9.822395 |
|---|
| 856 | 40|qPDF|s3.47 MB|uhttps://publications.gc.ca/collections/collection_2017/irsc-cihr/MR4-53-2016-eng.pdf |
|---|